Sequencing of Ipilimumab Plus Nivolumab and Encorafenib Plus Binimetinib for Untreated BRAF-Mutated Metastatic Melanoma (SECOMBIT): A Randomized, Three-Arm, Open-Label Phase II Trial

Ascierto, PA (author)

Mandalà, M (author)

Ferrucci, PF (author)

show more...

Guidoboni, M (author)

Rutkowski, P (author)

Ferraresi, V (author)

Arance, A (author)

Guida, M (author)

Maiello, E (author)

Gogas, H (author)

Richtig, E (author)

Fierro, MT (author)

Lebbè, C (author)

Helgadottir, H (author)

Karolinska Institutet

Queirolo, P (author)

Spagnolo, F (author)

Tucci, M (author)

Del Vecchio, M (author)

Gonzales Cao, M (author)

Minisini, AM (author)

De Placido, S (author)

Sanmamed, MF (author)

Mallardo, D (author)

Curvietto, M (author)

Melero, I (author)

Palmieri, G (author)

Grimaldi, AM (author)

Giannarelli, D (author)

Dummer, R (author)

Chiarion Sileni, V (author)

show less...

 (creator_code:org_t)

2023

2023

English.

In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. - 1527-7755. ; 41:2, s. 212-221

Related links:

http://kipublication...

show more...

https://doi.org/10.1...

show less...

• Journal article (peer-reviewed)